IPO registrations (S-1, F-1) · Registrants
APPLIED NEUROSOLUTIONS INC
- SEC CIK
- 872947 · filings on EDGAR ↗
- Name on the registration
- OPHIDIAN PHARMACEUTICALS INC
- Former names
- HEMOXYMED INC (2002–2004); OPHIDIAN PHARMACEUTICALS INC (1997–2002)
- Registration
- Form S-1, first filed 1997-08-08, last 1998-05-06; 1 initial registration, 10 amendments
- Outcome
- Final prospectus filed 1998-05-07; withdrawal requested 1998-05-04
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 50 LAKEVIEW PARKWAY S, STE 111, Vernon Hills, IL 60061
- EIN
- 39-1661164
- EDGAR entity type
- operating
- Insiders and CEO pay
- APPLIED NEUROSOLUTIONS INC on the corporate pages
Offering terms
- Final price
- $7.32 per share (424B1 filed 1998-05-07, an initial public offering)
- Shares sold
- 1,750,000
- Gross proceeds
- $12,810,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol OPHDU
- Lead underwriters
- Dirks & Company, Inc (700,000 shares); Security Capital Trading, Inc (150,000 shares)
- Syndicate
- Dirks & Company, Inc. Security Capital Trading, Inc; Kashner Davidson Securities Corporation (200,000); Westport Resources Investment Services (200,000); Cohig & Associates, Inc (100,000); Frederick & Company, Inc (100,000); Laidlaw Global Securities, Inc (100,000); National Securities Corporation (100,000); Smith, Moore & Co (100,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: APPLIED NEUROSOLUTIONS, INC. EXACT (EIN (EXACT))
- SEC filer: APPLIED NEUROSOLUTIONS INC EXACT (CIK (EXACT))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1997-08-08 | S-1 | S-1 (registration) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-97-004128 ↗ |
| 1997-11-10 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-97-005770 ↗ |
| 1997-11-12 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-97-005877 ↗ |
| 1998-01-27 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-000405 ↗ |
| 1998-01-29 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-000435 ↗ |
| 1998-02-05 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-000557 ↗ |
| 1998-02-17 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-000764 ↗ |
| 1998-02-20 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-000849 ↗ |
| 1998-03-19 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-001428 ↗ |
| 1998-04-29 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-002424 ↗ |
| 1998-05-04 | RW | RW (withdrawal request) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-002566 ↗ |
| 1998-05-06 | S-1/A | S-1/A (amendment) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-002602 ↗ |
| 1998-05-07 | S-1MEF | S-1MEF (added securities) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-002617 ↗ |
| 1998-05-07 | 424B1 | 424B1 (final prospectus) | OPHIDIAN PHARMACEUTICALS INC | 0000950124-98-002642 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1998-05-06 | S-1/A | registration statement | $6.10 | 1,600,000 | $9,760,000 | Nasdaq OPHDU | 1 | from the submission text; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 1998-05-07 | 424B1 | final prospectus | $7.32 | 1,750,000 | $12,810,000 | Nasdaq OPHDU | 10 | from the submission text; price sentence, shares general, proceeds computed, underwriting table 9, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| LANGNER JAY B | Director | 2 | 2006–2008 | ||
| SORELL MICHAEL | Director | 1 | 2006 | ||
| VATERS ROBERT S | Director | 4 | 2006–2008 | ||
| MARXE AUSTIN W & GREENHOUSE DAVID M | TenPercentOwner | 1 | 2006 | ||
| HELLER ALAN L | Director | 8 | 2006–2009 | ||
| Hoffing Ellen Randi | Director; Director,Officer | President and CEO; President & CEO; President & CEO | 9 | 2006–2010 | |
| ELLISON DAVID J | Officer | Chief Financial Officer | 2 | 2007–2009 | |
| ROTH MICHAEL | TenPercentOwner | 20 | 2007–2010 | ||
| STARK BRIAN JAY | TenPercentOwner | 20 | 2007–2010 | ||
| Tiemeier David C | Director | 5 | 2007–2010 | ||
| OGUNRO EDWARD A | Director | 4 | 2008–2010 | ||
| PARKS GARY C | Director | 4 | 2008–2010 | ||
| TAYLOR CRAIG S | Director,Officer | President & CEO | 2 | 2009 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | APPLIED NEUROSOLUTIONS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | APPLIED NEUROSOLUTIONS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), IL first:
- AveXis, Inc. IL
- BioLife4D Corp IL
- Viskase Holdings, Inc. IL
- NEOPHARM INC IL
- BioNTech SE 2M
- Immatics N.V. 2M
- CHEMOKINE THERAPEUTICS CORP A1
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
In other datasets, the same topic (Health) in IL:
- Nonprofit: 5 LOAVES 2 FISHES FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health